parallel sessions - International Society for Blood Transfusion

PostersISBT2006PostersTOPIC 01.2TOPIC 01.3The posters areon display fromMonday - ThursdayP-082 HBV DNA DETECTION IN HBSAG NEGATIVE/ANTI-CORE POSITIVEITALIAN FIRST TIME BLOOD DONORSP-089 ABILITY OF THE MACOPHARMA PRION CAPTURE (P-CAPTTM)FILTER TO REMOVE BRAIN PRPRES IN LEUKOREDUCED HUMAN RBCC. Velati, L. Romanò, L. Fomiatti, G. Cambiè, A. Zanetti (Dipartimento di MedicinaL.G. Gregori, B. Lambert, R. Rohwer (VA Medical Center, Baltimore, United States of America)Trasfusionale, Sondrio, Italy)P-083 TRANSFUSION-TRANSMITTED DISEASES AND THEIR FREQUENCYCHANGE BY THE YEARS IN BLOOD DONORS OF A HOSPITAL BLOODBANK IN GREECEP-090 IN VITRO EVALUATION OF RED CELL CONCENTRATES AFTERFILTRATION OVER THE NEW COMPOSAFE PR SYSTEM (SYSTEM FORPRION REDUCTION FROM LEUKOCYTE DEPLETED RCC)D. de Korte, R. Vlaar, C.W.N. Gouwerok, M. Kleine, S. Borghi, A.J. VerhoevenK. Ziciadis, F. Karabini, E. Xanthi, A. Tzolou, E. Chrisostomou, E. Zervou (University Hospital of(Sanquin Research, Amsterdam, Netherlands)Ioannina, Ioannina, Greece)P-084 THE STRATEGY FOR ELIMINATING HBV. TRANSMISSION THROUGHBLOOD TRANSFUSION IN UNITED ARAB EMIRATESP-091 DETECTION OF INFECTIOUS PRION IN BLOOD BY PROTEINMISFOLDING CYCLIC AMPLIFICATION TECHNOLOGY (PMCA)F. Leon, C. Segarra, J. Coste (Etablissement Français du Sang, Montpellier, France)78A.H.A. Al Amiri (Ministry of Health, Sharjah, United Arab Emirates)P-085 EVIDENCE ON ANTI-HBc REACTIVITY AMONG GREEK BLOODDONORS AND CORRELATION BETWEEN ANTI-HBc TITRE AND THEPRESENCE OF HBV DNAP-092 REMOVAL OF THE ENDOGENOUS TSE INFECTIVITY PRESENT INBLOOD USING PRDT TSE AFFINITY LIGANDS AND INTEGRATION OF THELIGANDS INTO THE MACOPHARMA P-CAPT(TM) FILTERG. Rohwer, L. Gregori, P. Gurgel, J. Lathrop, P. Edwardson, B. Lambert, R.G. Carbonell,79A. Varaklioti, I. Kalfa, A. Kapsalis, A. Kouramba, P. Kotsi, A. KarafoulidouS.J.B. Burton, D.J.H. Hammond (VA Maryland Health Care System, Baltimore,(2nd Blood Transfusion Center, Athens, Greece)United States of America)Topic 01.3P-093 WHAT DIFFERENCE IN PRION PROTEIN EXPRESSION ANDPROCESSING IN HUMAN BLOOD CELLS BETWEEN METHIONINE HOMO-ZYGOUS AND VALINE DONORS AT CODON 129 OF THE PRNP GENEBlood Safety - TTD - TSEsC. Segarra, S. Lehmann, J. Coste (Etablissement Français du Sang, Montpellier, France)P-086 HIGH RATE OF VCJD TRANSMISSION IN MICE BY INTRAVENOUSINOCULATION OF WHOLE BLOODL. Cervenakova, O. Yakovleva, C. McKenzie (J.H.Holland Laboratory, ARC, Rockville,United States of America)Topic 01.4.Blood Safety - TTD - West Nile VirusP-087 PERFORMANCE CHARACTERISTICS OF PALL’S ENHANCEDLEUKOTRAP AFFINITY PRION REDUCTION FILTERP-094 WEST NILE VIRUS (WNV) AND DENGUE VIRUS (DV) ARE LOW RISKFOR TRANSFUSION IN GHANAO. Coker, F. Andrade, S. Pesci, T. Budziak, F. Madraswalla, J. Peterson, B. Selman,J.P. Allain, C. Li, K. Danso, E. Addo-Yobo, S. Owusu-Ofori (University of Cambridge,G. DelGiacco (Pall Corporation, Port Washington, United States of America)Cambridge, United Kingdom)P-088 CREUTZFELDT-JAKOB DISEASE LOOK-BACK STUDY: AN UPDATEK.A. Dorsey, S. Zou, E.P. Notari, C.T. Fang, R.Y. Dodd, L.B. Schonberger (American RedP-095 MONITORING OF GENETIC VARIABILITY OF WEST NILE VIRUS INBLOOD DONOR SPECIMENS USING A MICROARRAY-BASED ASSAYCross, Rockville, United States of America)M. Rios, A. Grinev, S. Daniel, M. Laassri, V. Chizhikov, K. Chumakov, I.K. Hewlett(CBER/FDA, Bethesda, United States of America)INTERNATIONAL SOCIETY OF BLOOD TRANSFUSIONXXIX THINTERNATIONAL CONGRESS OF THE ISBT